The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

@article{Canfell2004ThePE,
  title={The predicted effect of changes in cervical screening practice in the UK: results from a modelling study},
  author={Karen Canfell and Ruanne V Barnabas and Julietta Patnick and Valerie Beral},
  journal={British Journal of Cancer},
  year={2004},
  volume={91},
  pages={530 - 536}
}
In 2003, the National Health Service Cervical Screening Programme (NHSCSP) announced that its screening interval would be reduced to 3 years in women aged 25–49 and fixed at 5 years in those aged 50–64, and that women under 25 years will no longer be invited for screening. In order to assess these and possible further changes to cervical screening practice in the UK, we constructed a mathematical model of cervical HPV infection, cervical intraepithelial neoplasia and invasive cervical cancer… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany

Journal of Public Health • 2008
View 15 Excerpts
Highly Influenced

Cost-effectiveness of human papillomavirus vaccination in Germany

Cost effectiveness and resource allocation : C/E • 2017

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

Journal of the National Cancer Institute. Monographs • 2003
View 3 Excerpts
Highly Influenced

The potential public health impact of vaccines against human papillomavirus

RV Barnabas, GP Garnett
European Consortium for Cervical Cancer Education, • 2004
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…